Evaluation of circulating plasma proteins in prostate cancer using mendelian randomization.

This study explores the genetic associations between plasma proteins and PCa, provides evidence that plasma proteins serve as potential drug targets and enhances the understanding of the molecular etiology, prevention and treatment of PCa.